September 12th 2024
The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Should I Add an Online Pharmacy to Increase My Practice Revenues?
July 1st 2003Dr. Dave is always looking for ways to increase his practice revenues. In his practice, he has a good mix of general and surgical dermatology patients, has learned to ethically promote his talents, and has launched a successful Web site. He ponders what else he can do to increase revenues.
Giving Bureaucracy the Ol' College Try
July 1st 2003Having recently returned to my "roots" to assume the position of professor and chief of dermatology at my alma mater, the University of Arizona, I'm struck by the fact that, although many changes have occurred during the 30 years I've been away pursuing other academic positions and activities, much remains the same. Predictably, the campus has grown and
Bucking the One-Time Trendsetter
June 1st 2003San Francisco - According to an analysis of data from more than 700 patients, a new nonsteroid treatment for atopic dermatitis is a safe, effective, and cost-effective alternative to conventional therapy for the chronic, relapsing inflammatory skin disease that primarily affects infants and children.
TIM's: Trying to Draw Comparisons
June 1st 2003San Francisco -- Results of a study evaluating topical tacrolimus ointment 0.03 percent (Protopic) indicate it is a safe and effective treatment for patients of all ages with mild to moderate atopic dermatitis (AD), John Y M Koo, M.D., said at the annual meeting of the American Academy of Dermatology.